Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The impact of COVID-19 on ALL patients in Spain
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
The impact of COVID-19 on ALL patients in Spain ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
22 Jul 2020
How should we manage patients with acute lymphoblastic leukaemia during COVID-19...
Dr Christopher Benton - Rocky Mountain Cancer Centers, Denver, USA
How should we manage patients with acute lymphoblastic leukaemia during COVID-19? ( Dr Christopher Benton - Rocky Mountain Cancer Centers, Denver, USA )
20 Jul 2020
Evaluating the impact of daratumumab for the treatment of multiple myeloma accor...
Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA
Evaluating the impact of daratumumab for the treatment of multiple myeloma according to cytogenetic risk ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )
10 Jul 2020
MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD res...
Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA
MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD response-adapted consolidation in NDMM ( Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA )
9 Jul 2020
UKALL2011: Treatment with a tyrosine kinase inhibitor improves outcomes for pati...
Prof Anthony Moorman - Newcastle University, Newcastle upon Tyne, UK
UKALL2011: Treatment with a tyrosine kinase inhibitor improves outcomes for patients with acute lymphoblastic leukaemia and an ABL-class fusion ( Prof Anthony Moorman - Newcastle University, Newcastle upon Tyne, UK )
9 Jul 2020
Long-term disease control in multiple myeloma by in-class transitioning: A commu...
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
Long-term disease control in multiple myeloma by in-class transitioning: A community-based study ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )
3 Jul 2020
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma ( Dr Elias Jabbour -  MD Anderson Cancer Center, Houston, USA )
3 Jul 2020
Treating acute lymphoblastic leukaemia in the era of COVID-19
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Treating acute lymphoblastic leukaemia in the era of COVID-19 ( Dr Elias Jabbour -  MD Anderson Cancer Center, Houston, USA )
3 Jul 2020
Managing acute myeloid leukaemia during the COVID-19 pandemic
Dr Naval Daver - MD Anderson Cancer Center, Houston, USA
Managing acute myeloid leukaemia during the COVID-19 pandemic ( Dr Naval Daver - MD Anderson Cancer Center, Houston, USA )
1 Jul 2020
Gut microbiome disturbance by antibiotic treatment early in life is sufficient t...
Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Sala...
Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice ( Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Salamanca, Spain )
30 Jun 2020
Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with r...
Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA
Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL ( Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA )
30 Jun 2020
Using the novel antibody-drug conjugate, loncastuximab tesirine to treat patient...
Prof Carmelo Carlo-Stella - Humanitas Cancer Center, Milan, Italy
Using the novel antibody-drug conjugate, loncastuximab tesirine to treat patients with R/R diffuse large B-cell lymphoma ( Prof Carmelo Carlo-Stella - Humanitas Cancer Center, Milan, Italy )
26 Jun 2020